Skip to main content

Pfizer scientist says mRNA technology used for Covid vaccines could create 'more potent' seasonal flu shots

The mRNA technology used to develop the Pfizer-BioNTech Covid-19 vaccine could help create "more potent" seasonal flu shots, Pfizer's Kathrin Jansen told CNBC.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.